Jeffrey D Klausner Selected Research

Reagins

1/2022	Laboratory Evaluation of the DPP Syphilis Screen & Confirm Assay.
12/2020	Clinical trial protocol to evaluate the efficacy of cefixime in the treatment of early syphilis.
1/2019	Performance of a Dual Human Immunodeficiency Virus/Syphilis Rapid Test Compared With Conventional Serological Testing for Syphilis and Human Immunodeficiency Virus in a Laboratory Setting: Results From the Zimbabwe STI Etiology Study.
1/2019	Serological Markers for Syphilis Among Persons Presenting With Syndromes Associated With Sexually Transmitted Infections: Results From the Zimbabwe STI Etiology Study.
1/2018	Use of Oral Fluid With a Rapid Treponemal Test for Syphilis Evaluation.
11/2017	The PICASSO Cohort: baseline characteristics of a cohort of men who have sex with men and male-to-female transgender women at high risk for syphilis infection in Lima, Peru.
1/2017	Demographics, Behaviors, and Sexual Health Characteristics of High Risk Men Who Have Sex With Men and Transgender Women Who Use Social Media to Meet Sex Partners in Lima, Peru.
3/2006	Syphilis treatment and HIV infection in a population-based study of persons at high risk for sexually transmitted disease/HIV infection in Lima, Peru.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey D Klausner Research Topics

Disease

62	Infections 12/2021 - 01/2002
52	Sexually Transmitted Diseases (Sexually Transmitted Disease) 03/2022 - 01/2002
51	Syphilis 01/2022 - 08/2003
40	HIV Infections (HIV Infection) 01/2021 - 12/2003
17	Gonorrhea 01/2022 - 01/2002
7	COVID-19 08/2022 - 01/2021
7	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 03/2002
6	Reinfection 12/2013 - 06/2003
3	Communicable Diseases (Infectious Diseases) 01/2020 - 11/2006
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 11/2006
3	Bacterial Vaginosis 01/2017 - 12/2009
3	Tuberculosis (Tuberculoses) 05/2015 - 09/2013
2	Coinfection 10/2019 - 11/2016
2	Cryptococcal Meningitis 01/2019 - 01/2014
2	Vaginal Discharge 01/2019 - 06/2015
2	Nausea 09/2016 - 01/2016
2	Viremia 01/2015 - 01/2010
2	secondary Syphilis 08/2013 - 10/2004
1	Sepsis (Septicemia) 12/2021
1	Clinical Deterioration 12/2021
1	Urologic Neoplasms (Urological Cancer) 01/2021
1	Yaws 01/2021
1	Lymphogranuloma Venereum 01/2021
1	Disease Progression 01/2021
1	Latent Syphilis 12/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2020
1	Substance-Related Disorders (Drug Abuse) 01/2020
1	Cellulitis 12/2019
1	Schistosomiasis haematobia (Schistosomiasis haematobium) 10/2019
1	White Dot Syndromes 01/2019
1	Meningitis 01/2019
1	Neoplasms (Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

17	RNA (Ribonucleic Acid)IBA 07/2019 - 10/2004
16	AntibodiesIBA 01/2022 - 02/2008
13	Pharmaceutical PreparationsIBA 01/2019 - 04/2002
13	Nucleic AcidsIBA 01/2017 - 08/2003
12	AntigensIBA 01/2021 - 08/2009
11	EnzymesIBA 12/2021 - 05/2006
8	ReaginsIBA 01/2022 - 03/2006
7	VaccinesIBA 08/2022 - 01/2018
7	Azithromycin (Zithromax)FDA LinkGeneric 01/2021 - 01/2006
7	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2021 - 04/2007
6	Immunoglobulin G (IgG)IBA 12/2021 - 11/2006
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2002
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2008
5	Doxycycline (Periostat)FDA LinkGeneric 01/2021 - 03/2006
5	Penicillins (Penicillin)FDA Link 12/2013 - 01/2006
4	CytokinesIBA 12/2021 - 09/2013
4	Biological ProductsIBA 11/2013 - 11/2006
4	Methamphetamine (Desoxyn)FDA LinkGeneric 08/2013 - 07/2005
4	Sildenafil Citrate (Viagra)FDA Link 08/2007 - 07/2002
3	ImmunosorbentsIBA 12/2021 - 11/2008
3	MacrolidesIBA 12/2021 - 02/2006
3	Penicillin G Benzathine (Benzathine Benzylpenicillin)FDA Link 12/2020 - 01/2013
3	Contraceptive Agents (Contraceptives)IBA 06/2018 - 01/2005
2	Messenger RNA (mRNA)IBA 08/2022 - 12/2021
2	Membrane Proteins (Integral Membrane Proteins)IBA 12/2021 - 01/2021
2	Cefixime (Suprax)FDA Link 01/2021 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2021
2	Emtricitabine (Emtriva)FDA Link 09/2016 - 01/2016
2	RacivirIBA 09/2016 - 01/2016
2	Tenofovir (Viread)FDA Link 09/2016 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2016 - 12/2013
2	Papillomavirus Vaccines (HPV Vaccines)IBA 04/2015 - 08/2009
2	Immunoglobulin M (IgM)IBA 03/2014 - 06/2011
2	Anti-Infective Agents (Microbicides)IBA 01/2013 - 04/2004
2	3- (2- pyridyl)- 5,6- diphenyl- 1,2,4- triazineIBA 08/2010 - 03/2006
2	Ligases (Synthetase)IBA 07/2002 - 01/2002
1	2019-nCoV Vaccine mRNA-1273IBA 08/2022
1	COVID-19 vaccine booster shotIBA 08/2022
1	COVID-19 VaccinesIBA 08/2022
1	BNT162 VaccineIBA 08/2022
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2022
1	mRNA VaccinesIBA 12/2021
1	Sigma-1 ReceptorIBA 12/2021
1	Fluvoxamine (Luvox)FDA LinkGeneric 12/2021
1	Surface Antigens (Surface Antigen)IBA 12/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2021
1	Serine (L-Serine)FDA Link 01/2021
1	Codon (Codons)IBA 01/2021
1	trans-crotonin (CTN)IBA 01/2020
1	antineoplaston A10 (A 10)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	mesoglycanIBA 01/2019
1	Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine FDA Link 01/2019
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Flucytosine (Ancobon)FDA Link 01/2019

Therapy/Procedure

16	Therapeutics 11/2021 - 06/2003
15	Male Circumcision 01/2021 - 11/2006
11	Condoms (Condom) 01/2020 - 11/2003
7	Prenatal Care (Care, Prenatal) 03/2022 - 01/2017
5	Aftercare (After-Treatment) 03/2016 - 09/2007
4	Chemoprevention 10/2019 - 07/2011
3	Time-to-Treatment 01/2019 - 05/2016
3	Ambulatory Care (Outpatient Care) 04/2009 - 05/2008
2	Self-Testing 05/2017 - 01/2017
2	Length of Stay 05/2015 - 07/2014
1	Drug Therapy (Chemotherapy) 01/2021
1	Slit Lamp 01/2019